RANZCP homepage
Date
21 March 2026
9am - 12 noon AEDT
Organised by
RANZCPDelivery
OnlineADHD in adults
Deepen your understanding of adult ADHD in this advanced masterclass led by internationally recognised experts Professor David Coghill, Dr Belinda Oddy, and Professor Shuichi Suetani.
Designed for clinicians with existing foundational knowledge, the session provides deep insights and clinical perspectives on complex ADHD presentations and practical approaches to management.
Proudly presented by the RANZCP Foundation—the charitable arm of the College—with all funds raised supporting research and leadership initiatives.
Topics covered
- ADHD with co-existing mental health problems
- Unrecognised and untreated, over-diagnosed or mis-diagnosed?
- ADHD in girls and women
- ADHD in primary healthcare settings
Don’t miss this exceptional opportunity to learn from leading experts and clinicians — and bring your questions to the interactive Q&A session.
What's included
- Live session with Q&A
- On‑demand access to the recording, slides and Q&A until 30 June 2027
- 3 CPD hours
Pricing
Member Type | Price |
RANZCP Fellow or Affiliate Member | $195 |
RANZCP Trainee | $160 |
Medical students | $100 |
Other medical practitioner | $215 |
Allied health / non - medical | $160 |
Presenters
Professor David Coghill
ADHD in adults with co-occurring mental health conditions
ADHD frequently persists into adulthood and when it does it frequently co-occurs with other mental health conditions. While the recent Royal Commission highlighted the under recognition and treatment of ADHD in many parts of Australia there is also considerable discussion about possible misdiagnosis and unnecessary treatment. It is very likely that both over and under recognition are happening and we will consider ways to reduce both.
ADHD is common in general psychiatry practice with significant rates of ADHD in adults with major depressive disorder, psychosis, bipolar disorder, personality disorder, eating disorders and substance use disorder. These coexisting conditions impact on the course, impairment and treatment of ADHD and reinforce the importance of considering: Could ADHD be contributing to this clinical presentation?
This session will look at the common co-occurring conditions with a focus on distinguishing between ADHD and other conditions and the more important treatment implications.
More about Professor Coghill
Prof Coghill has been working as a clinician and researcher in the field of ADHD for almost 30 years. His research spans both basic and clinical science with a strong emphasis on translation and implementation of evidence into practice. He is recognised in Expertscape as #4 for ADHD globally and #1 in Australia. He has made a major contribution to the understanding of the relationships between ADHD symptoms and cognition and the impact and safety of ADHD medications. He has maintained a strong clinical focus and his Dundee Model for ADHD Care that emphasised the importance out measurement-based care approaches in optimising clinical outcomes. This pathway has become the blueprint for clinical pathways worldwide.
He is currently leading the Lancet Psychiatry Series on ADHD which brings together a global group of ADHD experts and clinicians to better understand the stigma, economic burden, epidemiology, and barriers to care for people living with ADHD in low-and-middle-income countries.
He is the President of the Australian ADHD Professionals Association (AADPA) and the medical lead for the neurodevelopmental disorders stream at the Parkville Youth Mental Health and Wellbeing service.
ADHD in adults with co-occurring mental health conditions
ADHD frequently persists into adulthood and when it does it frequently co-occurs with other mental health conditions. While the recent Royal Commission highlighted the under recognition and treatment of ADHD in many parts of Australia there is also considerable discussion about possible misdiagnosis and unnecessary treatment. It is very likely that both over and under recognition are happening and we will consider ways to reduce both.
ADHD is common in general psychiatry practice with significant rates of ADHD in adults with major depressive disorder, psychosis, bipolar disorder, personality disorder, eating disorders and substance use disorder. These coexisting conditions impact on the course, impairment and treatment of ADHD and reinforce the importance of considering: Could ADHD be contributing to this clinical presentation?
This session will look at the common co-occurring conditions with a focus on distinguishing between ADHD and other conditions and the more important treatment implications.
More about Professor Coghill
Prof Coghill has been working as a clinician and researcher in the field of ADHD for almost 30 years. His research spans both basic and clinical science with a strong emphasis on translation and implementation of evidence into practice. He is recognised in Expertscape as #4 for ADHD globally and #1 in Australia. He has made a major contribution to the understanding of the relationships between ADHD symptoms and cognition and the impact and safety of ADHD medications. He has maintained a strong clinical focus and his Dundee Model for ADHD Care that emphasised the importance out measurement-based care approaches in optimising clinical outcomes. This pathway has become the blueprint for clinical pathways worldwide.
He is currently leading the Lancet Psychiatry Series on ADHD which brings together a global group of ADHD experts and clinicians to better understand the stigma, economic burden, epidemiology, and barriers to care for people living with ADHD in low-and-middle-income countries.
He is the President of the Australian ADHD Professionals Association (AADPA) and the medical lead for the neurodevelopmental disorders stream at the Parkville Youth Mental Health and Wellbeing service.
Dr Belinda Oddy
ADHD in girls and women
Dr Belinda Oddy is an adult psychiatrist working at the Royal Brisbane and Women's Hospital and in private practice in the areas of ADHD, Addiction Psychiatry and Consultation-Liaison Psychiatry.
In her presentation, she will discuss ADHD in girls and women.
ADHD in girls and women
Dr Belinda Oddy is an adult psychiatrist working at the Royal Brisbane and Women's Hospital and in private practice in the areas of ADHD, Addiction Psychiatry and Consultation-Liaison Psychiatry.
In her presentation, she will discuss ADHD in girls and women.
Professor Shuichi Suetani
ADHD in primary healthcare settings
Shuichi works as Senior Psychiatrist at the Institute for Urban Indigenous Health in Brisbane, the largest Aboriginal Community Controlled Organisation in Australia. In his presentation, he will outline the strategies and steps involved in establishing primary health ADHD care pathways for Indigenous peoples in South East Queensland.
He will also discuss how this work aligns with the recent policy change that has allowed GPs in Queensland to diagnose and treat adults with ADHD from December 2025.
ADHD in primary healthcare settings
Shuichi works as Senior Psychiatrist at the Institute for Urban Indigenous Health in Brisbane, the largest Aboriginal Community Controlled Organisation in Australia. In his presentation, he will outline the strategies and steps involved in establishing primary health ADHD care pathways for Indigenous peoples in South East Queensland.
He will also discuss how this work aligns with the recent policy change that has allowed GPs in Queensland to diagnose and treat adults with ADHD from December 2025.
Your registration supports research and leadership
Your registration fee is donated to the RANZCP Foundation — the charitable arm of the College.
Each year, the Foundation invests around $250,000 in grants and scholarships to nurture the next generation of psychiatric researchers and strengthen the academic foundations of our profession.
We are also proud to support Indigenous leadership programs, helping to build capacity and foster inclusive excellence.
Other resources
RANZCP Position Statements
CPD Hours
This Masterclass will give you up to 3 CPD hours.
RANZCP Member:
We will upload your registration to MyCPD portal as a draft activity. Instead of receiving a certificate of attendance, you'll need to log in to your MyCPD account to complete a reflection and submit your draft activity. More information on how to confirm a draft CPD activity.
Others:
If you are not a member of the RANZCP, you may request a certificate of attendance by emailing events@ranzcp.org. Please check with your certifying organisation if you are eligible for CPD points for the masterclass.
Delegate Cancellation
To cancel your registration, please email foundation@ranzcp.org. Refunds are provided in accordance with the RANZCP refund policy.
Disclaimer
The information provided in this Masterclass is intended to provide educational and general guidance to practitioners and should not be relied on as a substitute for proper assessment with respect to the merits of each case and the needs of the patient.
The information may represent views of the author and not necessarily the views of the RANZCP. All case examples are de identified. Information is subject to change and the RANZCP does not warrant that the information is current at the time of viewing and accepts no liability for any loss or damage suffered by you or any person (including Allied Health, patients and carers) directly or indirectly, as a result of relying on the information provided and should not be a substitute for individual clinical judgement.
Always seek the advice of a qualified health provider regarding a medical condition. Please note that the medications discussed require a medical prescription, and prescribing requirements may vary across jurisdictions.
By accessing e-learning sessions you also agree to the RANZCP Website Terms of Use Agreement.
Recording
The on-demand version will be available until 30 June 2027.
